Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34+ skin stem cells and skin tumors

Carcinogenesis

Volumn 34, Issue 6, 2013, Pages 1315-1322

  Chiou, Yi Shiou ^a,e   Sang, Shengmin ^b   Cheng, Kuang Hung ^c   Ho, Chi Tang ^d   Wang, Ying Jan ^e   Pan, Min Hsiung ^a  

^a NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^b NORTH CAROLINA A AND T STATE UNIVERSITY   (United States)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^d RUTGERS UNIVERSITY   (United States)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

4 O METHYLPHORBOL 13 ACETATE 12 MYRISTATE; CD34 ANTIGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN B; CYCLIN DEPENDENT KINASE 1; CYCLOOXYGENASE 2; DIMETHYLBENZ[A]ANTHRACENE; EPIGALLOCATECHIN GALLATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 9; ORNITHINE DECARBOXYLASE; PHOSPHATIDYLINOSITOL 3 KINASE; POLYCYSTIN 1; PROTEIN KINASE B; PROTEIN P21; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE 1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; MALE; MITOSIS INDEX; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN TUMOR; STEM CELL; TUMOR GROWTH;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ACETATES; ANIMALS; ANTIGENS, CD34; CATECHIN; CCAAT-ENHANCER-BINDING PROTEINS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHEMOPREVENTION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLOOXYGENASE 2; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; MICE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; MITOTIC INDEX; NITRIC OXIDE SYNTHASE TYPE II; ORNITHINE DECARBOXYLASE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-AKT; SKIN NEOPLASMS; STEM CELLS; TETRADECANOYLPHORBOL ACETATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84878963619     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt042     Document Type: Article

References (40)

1. +/K15+ keratinocyte stem cells and skin tumors during multi-stage mouse skin carcinogenesis. Anticancer Res., 26, 2805-2820.
2. Malanchi,I. et al. (2008) Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature, 452, 650-653.
3. Ivanova,P. et al. (2008) Knockdown of PKD1 in normal human epidermal keratinocytes increases mRNA expression of keratin 10 and involucrin: early markers of keratinocyte differentiation. Arch. Dermatol. Res., 300, 139-145.
4. Ristich,V.L. et al. (2006) Protein kinase D distribution in normal human epidermis, basal cell carcinoma and psoriasis. Br. J. Dermatol., 154, 586-593.
5. Bollag,W.B. et al. (2011) Ultraviolet activation of PKD: implications for skin cancer. Future Oncol., 7, 485-487.
6. Sundram,V. et al. (2011) Emerging roles of protein kinase D1 in cancer. Mol. Cancer Res., 9, 985-996.
7. Abel,E.L. et al. (2009) Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat. Protoc., 4, 1350-1362.
8. Gupta,S. et al. (2002) Chemoprevention of skin cancer: current status and future prospects. Cancer Metastasis Rev., 21, 363-380.
9. Singh,B.N. et al. (2011) Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem. Pharmacol., 82, 1807-1821.
10. Lambert,J.D. et al. (2006) Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate. Drug Metab. Dispos., 34, 2111-2116.
11. Landis-Piwowar,K.R. et al. (2007) A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Cancer Res., 67, 4303-4310.
12. Lee,S.C. et al. (2008) Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo. Nutr. Cancer, 60, 483-491.
13. Meeran,S.M. et al. (2011) A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells. Cancer Prev. Res. (Phila)., 4, 1243-1254.
14. Chiou,Y.S. et al. (2012) Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice. J. Agric. Food Chem., 60, 3441-3451.
15. Chiou,Y.S. et al. (2011) Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway. J. Agric. Food Chem., 59, 2725-2733.
16. Triantafyllou,A. et al. (2011) Anti-inflammatory activity of Chios mastic gum is associated with inhibition of TNF-alpha induced oxidative stress. Nutr. J., 10, 64.
17. Storz,P. et al. (2003) Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. EMBO J., 22, 109-120.
18. Roger,L. et al. (2006) Control of cell migration: a tumour suppressor function for p53? Biol. Cell, 98, 141-152.
19. Yao,D. et al. (2008) Fos cooperation with PTEN loss elicits keratoacanthoma not carcinoma, owing to p53/p21 WAF-induced differentiation triggered by GSK3beta inactivation and reduced AKT activity. J. Cell. Sci., 121(Pt 10), 1758-1769.
20. Zhao,Y. et al. (2002) Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model. Oncogene, 21, 3836-3846.
21. Hurlin,P.J. et al. (2004) Functions of myc:max in the control of cell proliferation and tumorigenesis. Int. Rev. Cytol., 238, 183-226.
22. Timofeev,O. et al. (2010) Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition. J. Biol. Chem., 285, 16978-16990.
23. Isoda,M. et al. (2009) The extracellular signal-regulated kinase-mitogenactivated protein kinase pathway phosphorylates and targets Cdc25A for SCF beta-TrCP-dependent degradation for cell cycle arrest. Mol. Biol. Cell, 20, 2186-2195.
24. Ernest,D.M. et al. (2005) Regulation of protein kinase D during differentiation and proliferation of primary mouse keratinocytes. J. Invest. Dermatol., 125, 294-306.
25. Fu,Y. et al. (2011) Protein kinase D: coupling extracellular stimuli to the regulation of cell physiology. EMBO Rep., 12, 785-796.
26. Trempus,C.S. et al. (2007) CD34 expression by hair follicle stem cells is required for skin tumor development in mice. Cancer Res., 67, 4173-4181.
27. Lai,C.S. et al. (2008) Anti-inflammatory and antitumor promotional effects of a novel urinary metabolite, 3',4'-didemethylnobiletin, derived from nobiletin. Carcinogenesis, 29, 2415-2424.
28. Chung,W.Y. et al. (2007) Xanthorrhizol inhibits 12-O-tetradecanoylphorbol- 13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogenactivated protein kinases and/or the nuclear factor-kappa B. Carcinogenesis, 28, 1224-1231.
29. Rozenberg,J. et al. (2009) Inhibition of CREB function in mouse epidermis reduces papilloma formation. Mol. Cancer Res., 7, 654-664.
30. Guo,J. et al. (2011) Protein kinase D isoforms are activated in an agonistspecific manner in cardiomyocytes. J. Biol. Chem., 286, 6500-6509.
31. Rozengurt,E. (2011) Protein kinase D signaling: multiple biological functions in health and disease. Physiology (Bethesda)., 26, 23-33.
32. Yuan,J. et al. (2008) Protein kinase D1 mediates NF-kappaB activation induced by cholecystokinin and cholinergic signaling in pancreatic acinar cells. Am. J. Physiol. Gastrointest. Liver Physiol., 295, G1190-G1201.
33. Lopez,J. et al. (2009) The context and potential of epigenetics in oncology. Br. J. Cancer, 100, 571-577.
34. Yuan,J. et al. (2004) Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene, 23, 5843-5852.
35. Zhao,Y. et al. (2006) Ras mutation promotes p53 activation and apoptosis of skin keratinocytes. Carcinogenesis, 27, 1692-1698.
36. Nantajit,D. et al. (2010) Cyclin B1/Cdk1 phosphorylation of mitochondrial p53 induces anti-apoptotic response. PLoS ONE, 5, e12341.
37. Rennecke,J. et al. (1999) Protein-kinase-Cmu expression correlates with enhanced keratinocyte proliferation in normal and neoplastic mouse epidermis and in cell culture. Int. J. Cancer, 80, 98-103.
38. Jadali,A. et al. (2010) Protein kinase D is implicated in the reversible commitment to differentiation in primary cultures of mouse keratinocytes. J. Biol. Chem., 285, 23387-23397.
39. Arun,S.N. et al. (2011) Ultraviolet B irradiation and activation of protein kinase D in primary mouse epidermal keratinocytes. Oncogene, 30, 1586-1596.
40. Arun,S.N. et al. (2010) The potential use of protein kinase D inhibitors for prevention/treatment of epidermal tumors. J. Dermatol. Sci., 60, 29-39.